Skip to main content
Metal-Based Drugs logoLink to Metal-Based Drugs
. 2001;8(2):103–105. doi: 10.1155/MBD.2001.103

Inhibitory Effects of Dimeric Copper(II) bis(o-acetoxybenzoate) on Platelet-neutrophil adhesion and Thrombosis

Zhiqiang Shen 1,✉, Lanou Wu 1, Weiping Liu 2, Jikai Liu 3, Zhihhe Chen 1
PMCID: PMC2365252  PMID: 18475982

Abstract

Antithrombotic effect of the copper-aspirin complex (dimeric copper(II) bis(o-acetoxybenzoate) was evaluated in the model of venous thrombosis; its effects on platelet-neutrophil adhesion were investigated by use of rosette assay. The results showed that the intragastrically administered copper-aspirin complex (5, 7, and 10 mg kg-1) dose-dependently lowered the wet and dry thrombus weight; it significantly decreased the binding of arachidonic acid-activated platelets to neutrophils with an IC50 value of 41.5 μmol L-1. The results suggested that copper aspirinate inhibited platelet-neutrophil adhesion and resulted in a more potent antithrombotic activity.

Full Text

The Full Text of this article is available as a PDF (505.5 KB).


Articles from Metal-Based Drugs are provided here courtesy of Wiley

RESOURCES